Stay updated with breaking news from Nasdaq Bmea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price lifted by Oppenheimer from $25.00 to $47.00 in a report published on Wednesday morning, The Fly reports. Oppenheimer currently has an outperform rating on the stock. A number of other analysts also recently weighed in on BMEA. HC Wainwright boosted their target price on Biomea […]
Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price lifted by Piper Sandler from $16.00 to $40.00 in a report released on Tuesday morning, The Fly reports. They currently have an overweight rating on the stock. Several other research analysts have also recently weighed in on the company. Citigroup began coverage on Biomea Fusion […]
Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price upped by Citigroup from $20.00 to $60.00 in a research note published on Wednesday morning, The Fly reports. The firm currently has a buy rating on the stock. BMEA has been the subject of several other research reports. HC Wainwright upped their price objective on […]
Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price raised by Piper Sandler from $16.00 to $40.00 in a report published on Tuesday morning, The Fly reports. Piper Sandler currently has an overweight rating on the stock. BMEA has been the topic of several other research reports. HC Wainwright reissued a buy rating and […]
REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company...